A gynecologic oncology group phase II trial of two p53 peptide vaccine approaches: subcutaneous injection and intravenous pulsed dendritic cells in high recurrence risk ovarian cancer patients

Overview of attention for article published in Cancer Immunology, Immunotherapy, September 2011

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (67th percentile)
Above-average Attention Score compared to outputs of the same age and source (57th percentile)

So far, Altmetric has seen 1 X post from an account with 845 followers.

A gynecologic oncology group phase II trial of two p53 peptide vaccine approaches: subcutaneous injectio... http://t.co/kgfGZSuz #HLA